Clinical trial
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and…
NCT00135642 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00135642 |
|---|---|
| Title | Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma |
| Official title | Randomized Double Blind Placebo Controlled Trial of Grass Pollen Immunotherapy Using a Cluster Regime |
| Lead sponsor | Imperial College London, Other |
| Collaborators | ALK-Abelló A/S Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Biological, Procedure |
| Interventions | Subcutaneous Alutard SQ grass pollen (Phleum pratense), Venepuncture: 20 ml blood sample taken on 2 separate visits |
| Enrollment | 44 |
| Start date | Feb 1, 1996 |
| Completion | Oct 1, 1998 |
| First posted | Aug 26, 2005 |
| Last update posted | Sep 14, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: